Atlas Trials

Pharmacokinetics, Tolerability and Safety of Favipiravir Compared to Ribavirin for the Treatment of Lassa Fever

Clinical trial NCT04907682 · COMPLETED

Trial details

NCT number
NCT04907682
Sponsor
Bernhard Nocht Institute for Tropical Medicine
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lassa Fever
Start date
2021-07-30
Primary completion
2022-11-10
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.